Rising Diabetes Cases and Medication Complexity
Type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases globally, including in Indonesia. In Lampung Province alone, more than 18,600 diabetes cases were recorded in Bandar Lampung in 2022, reflecting a growing public health burden.
As patients often require multiple medications to manage blood sugar and related conditions such as hypertension or cardiovascular disease, the risk of drug–drug interactions increases. These interactions can alter how medications work—either reducing their effectiveness or increasing the risk of harmful side effects.
This makes monitoring prescriptions a critical part of diabetes care, especially in outpatient settings where patients manage their treatment independently.
How the Study Was Conducted
The research team analyzed 100 medical records of type 2 diabetes outpatients treated at Advent Hospital in Bandar Lampung during 2024. The study used a descriptive quantitative design and selected records through accidental sampling.
Researchers reviewed prescriptions containing more than one medication and evaluated potential drug interactions using established drug databases, including Medscape, Drugs.com, and DrugBank.
They examined:
- Patient demographics (age and gender)
- Number and types of medications prescribed
- Types of antidiabetic drugs used
- Frequency, severity, and mechanisms of potential drug interactions
Key Findings: Most Prescriptions Carry Interaction Risks
The study found that drug interaction risks are widespread among diabetes patients:
- 76% of prescriptions contained at least one potential drug–drug interaction
- A total of 261 interaction cases were identified across 100 prescriptions
- Moderate interactions dominated (63.2%), followed by minor (30.3%) and major (6.5%)
Common Patient Profile
- 57% female, 43% male
- 72% aged 46–65 years
- Most prescriptions (87%) contained fewer than seven medications
Most Frequently Used Drugs
- Metformin was the most prescribed drug (30.9%)
- Sulfonylureas were the most common drug class (34.6%)
Most Common Interaction Types
- Pharmacokinetic interactions (50.6%)—affecting drug absorption, metabolism, or excretion
- Pharmacodynamic interactions (30.3%)—affecting how drugs act in the body
- Unknown mechanisms (19.2%)
Frequently Identified Drug Combinations
- Moderate risk: Ramipril + metformin (6.1%)
- Minor risk: Metformin + vitamin B12 (15.2%)
- Major risk: Lansoprazole + gliclazide (23.5%)
These combinations may increase risks such as hypoglycemia (dangerously low blood sugar), reduced drug effectiveness, or nutrient deficiencies.
Why These Findings Matter
Drug-drug interactions can significantly affect treatment outcomes in people with type 2 diabetes. Moderate interactions-while not immediately life-threatening-can still worsen side effects or require changes in therapy.
The study highlights that even prescriptions with fewer medications can still carry interaction risks, challenging the assumption that only “polypharmacy” (many drugs) leads to problems.
As the authors explain, the high rate of potential interactions “highlights the need for closer monitoring, improved evaluation of actual drug interactions, and enhanced patient education to reduce potential adverse outcomes.”
Real-World Implications for Healthcare
The findings have important implications for multiple stakeholders:
For Healthcare Providers
Doctors and pharmacists should:
- Carefully review prescriptions for possible interactions
- Monitor patients regularly, especially for blood glucose fluctuations
- Adjust drug combinations when necessary
For Patients
Patients with diabetes should:
- Inform healthcare providers about all medications they take
- Follow prescriptions carefully
- Report unusual symptoms such as dizziness, weakness, or hypoglycemia
For Health Systems and Policymakers
Hospitals and regulators may need to:
- Strengthen clinical pharmacy services
- Integrate drug interaction screening tools into prescribing systems
- Promote guidelines for safer diabetes treatment
Expert Insight from the Researchers
The research team from the Health Polytechnic of Tanjung Karang emphasizes that drug interaction risks are not just theoretical but require practical attention in clinical care.
They note that many interactions—especially those involving metformin—are predictable and manageable with proper monitoring and awareness.
0 Komentar